News | July 04, 2023
Biocon Biologics' Hulio Biosimilar to Humira now available in the US
The launch of HULIO in the United States is an important milestone for Biocon Biologics
The launch of HULIO in the United States is an important milestone for Biocon Biologics
Augnito’s AI comprehends all English accents with 99% accuracy
Antimicrobial Resistance (AMR) poses a significant threat to global healthcare systems and patient safety
Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
Gafchromic films support patient care in oncology
Healthcare leaders are heavily investing in AI or plan to do so for both critical decision support and operational efficiency, helping tackle staff shortages
Clinical Decision Support Systems' huge potential to help ensure that each patient can receive high-quality care; study shows a reduction in diagnostic errors from 24% to 2%
Enabling wireless monitoring In ambulances and homes
The introduction of Octasa 1600 mg to the Canadian market is expected to increase the options for UC patients managed with mesalazine.
Subscribe To Our Newsletter & Stay Updated
